Effect of sera of brain tumor patients on cytokine-induced human myelogenous leukemic cell differentiation.
Human myelogenous leukemic cell lines (ML-1, U-937, THP-1) were induced to differentiate by treatment with various cytokines such as tumor necrosis factor (TNF), interferon-gamma (IFN-gamma) and interleukin-6. Serum of normal humans efficiently stimulated this cytokine-induced differentiation, whereas the stimulating effect of serum of brain tumor patients was much less. Both normal and patient sera, at effective concentrations, only slightly affected the binding of 125I-TNF to ML-1 cells, but any of these sera significantly inhibited the binding of 125I-IFN-gamma to U-937 cells or to THP-1 cells. These results suggest that the weak differentiation-stimulating effect of the serum of brain tumor patients cannot be explained simply by the modification of the binding of these cytokines to cellular receptors.